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ABSTRACT 
 Multiple myeloma (MM) is an incurable malignancy of bone marrow plasma B cells and is 
associated with obesity. The mechanisms by which obesity contributes to MM risk remains 
unclear, however, we speculate the linking factor to be sleep apnea which we simulated by 
chronic intermittent hypoxia (CIH). 5TGM1 cells are a murine MM cell line derived from the 
KaLwRij strain that fail to routinely engraft in Black6 mice. To test the hypothesis that chronic 
intermittent hypoxia (CIH) promotes the development of MM, we exposed MM-resistant 
C57BL/6 mice to 10h/day of CIH during the light cycle (AHI=10-12/h) for 7 days, or static 21% 
oxygen as a control. On day 7, mice were injected with 1x106 GFP-labelled malignant mouse 
plasma cells (5TGM1) and the CIH was continued for an additional 28 days. 67% of the CIH 
mice developed MM, evidenced by paralysis, bone lesions in the spine, and plasmacytomas in 
the femur. It was also tested if the CIH effected the cells intrinsically. We hypothesized that CIH 
would promote the proliferation of 5TGM1 cells in culture. Two groups of 5TGM1 cells were 
plated in 18 gas permeable wells at a concentration of 500,000 cells/mL. One plate was placed in 
a plexiglass environmental control cabinet and the other plate was placed in a normoxia 
incubator.  The incubator was maintained at 21% O2 as a control. The environmental control 
cabinet, however, was maintained at an O2 level that decreased to 10% for 90s, every five 
minutes, for 10 hours per day. The control plate showed normal signs of proliferation. On the 
other hand, the plate maintained in CIH conditions showed rapid cell death as early as Day 2 of 
the experiment. These results suggest that the CIH conditions do not cause growth and 
proliferation of the 5TGM1 cell line. Therefore, we speculate that CIH may exert its MM-
promoting effects on the bone marrow stromal environment and not directly on the tumor. Future 
work in our laboratory will investigate the role of CIH in transforming the bone marrow 
microenvironment to allow for tumor cell engraftment. 
 Multiple Myeloma is a terminal cancer of plasma cells with a well described pre-malignant 
stage known as MGUS. In 2017 alone there were 30,280 new cases of MM with a death toll of 
12,590 people (American Cancer Society). In the bone marrow of MM patients the plasma cells 
proliferate in a cancerous manner and overcrowd the healthy cells. This leads to one of the 
defining characteristics of MM-anemia. MM patients are known to have some telltale signs that 
are known by the acronym CRAB. CRAB relays that these individuals typically have 
hyperCalcemia, Renal insufficiency, Anemia and Bone lesions. MM is more common in African 
Americans and individuals with first degree relatives with MM, showing a heritability 
component of MM. There have been improvements in the treatment for MM over the years; 
however, the condition is still incurable and individuals relapse. Prior to developing MM, 
individuals acquire monoclonal gammopathy of undetermined significance (MGUS). MGUS is 
an asymptomatic precursor state to MM and has a cumulative progression rate to MM of 1-2% 
per year. The mechanisms that advance MGUS to MM are still unknown, but understanding 
these mechanisms can potentially help prevent the progression of individuals from MGUS to 
MM.   
 Multiple Myeloma associated genetic mutations are insufficient to induce MM in mice. The 
genetic mutations in the human genome, point mutations, which are commonly associated with 
multiple myeloma are activating mutations in K-Ras and N-Ras (Chng et al., 2008; Lionetti et 
al., 2015). It was seen in multiple mouse models that activation of K-Ras was insufficient in 
producing MM in these mice. These mice were then crossed with genetically tumor prone mice 
strain, KaLwRij, and were still not seen to progress into MM. This suggest that the genetic 
component of MM alone is not sufficient in being the factor for the progression from MGUS to 
MM. Our overarching hypothesis is that CIH increases oxidative stress, thereby accelerating B 
cell maturation and changing the bone marrow stromal microenvironment to support the 
progression of MM in the context of genetic mutations. This project will establish the role of the 
environmental stress CIH in cooperating with genetic markers in MM pathogenesis and the 
mechanisms of that cooperation, which we hypothesize are mediated by reactive oxygen species 
effect on the bone marrow microenvironment. 
 Sleep apnea maybe culprit for the reason obese individuals have a higher risk of MM. 
Obesity is a morbidity that is on the rise around the world and has been correlated with the 
increased risk of many types of cancer including MM. If obesity rates stay consistent, by 2030, 
51 percent of America’s population will be obese by 2030. The physiology behind why obesity 
increases the chance of onset of MM is not fully understood. Similar to the genetic component, 
high fat diet alone again is insufficient from the development of MM in mice (Lwin et al., 2015). 
This led us to believe a comorbidity of obesity may need to be present in order to induce the 
higher risk of onset of MM. Nearly 45% of obese individuals have a complication known as 
sleep apnea (Young et al., 1993). Sleep apnea is when an individual has one or more pauses in 
breathing or shallow breaths while he or she sleeps. Breathing pauses can last from a few 
seconds to minutes. They may occur 30 times or more an hour (www.nhlbi.nih.gov). There is a 
strong correlation between severity of sleep apnea and cancer death that shows higher the 
severity of sleep apnea is correlated with higher frequency of death due to cancer (Miller et al., 
2013; Nieto et al., 2012; Peppard and Nieto, 2013). MM and sleep apnea even have similar risk 
factors such as age, male sex and African American race. This leads to the hypothesis of the first 
experiment: if black6mice are subjected to chronic intermittent hypoxia (CIH), then the 5TGM1 
cells will engraft and proliferate. CIH is the protocol used to simulate sleep apnea in the mice. If 
CIH induced intrinsic effects in the MM cell line, 5TGM1, was also tested in Experiment 2. The 
hypothesis for Experiment 2 was as follows: if 5TGM1 cells are subjected to chronic intermittent 
hypoxia, then the cells will proliferate in culture.  
METHODS 
Experiment 1: Engraftment and Progression of Multiple Myeloma Cells in Vivo 
I. Animal Model. 
 C57BL/6 mice and C57BL/KaLwRij were the two strains of mice we used in our experiments. 
All mice used in the experiment were 8 weeks olds and females. The C57BL/6 mice used in the 
following experiments were purchased from Jackson Laboratory in Bar Harbor, Maine. The 
C57BL/KaLwRij mice were bred in the animal facility at the University of Iowa in Iowa City, 
Iowa. All mice were housed in the same conditions: five mice per cage with food and water 
available at all times and with a 12 hour light cycle during day time and 12 dark cycle during 
nighttime. The University of Iowa Institutional Animal Care and Use Committee approved all 
studies involving these animals.  
II. Malignant Plasma Cell Line. 
 5TGM1 cells are murine myeloma cells that were derived from multiple myeloma in 
C57BL/KaLwRij mice. Multiple myeloma occurs spontaneously in aged C57BL/KaLwRij mice 
with no external stimulus such as CIH being required. The 5TGM1 cells used in our experiments 
were genetically engineered to express green fluorescent protein (GFP). The cells were cultured 
in RPMI 1640 medium (ATCC modification) (GIBCO, Grand Island, New York, USA) 
supplemented with 10% fetal bovine serum (HyClone Laboratories, Logan, Utah) and 1% 
penicillin-streptomycin solution (Mediatech, Manassas, Virginia) at 37ºC in 5% CO2 
atmosphere.  
III. Chronic Intermittent Hypoxia (CIH) Exposure  
 The mice experienced CIH in two plexiglass exposure chambers bought from Coy Laboratories 
in Grass Lake, Michigan. The CIH protocol was as follows: 10 hours of CIH during the light 
cycle due to the fact mice sleep during the light cycle, beginning of each cycle nitrogen was 
flushed into the chamber until 10% oxygen was reached within 30 seconds, 10% oxygen was 
maintained inside of the chamber for an additional 60 seconds, lastly oxygen is flushed into the 
chamber until a concentration of 21% O2 is reached and this is maintained until the end of the 5 
minute cycle. The CIH cycles are repeated for a duration of 10 hours or 120 cycles in total 
during the light cycle of the day. This CIH protocol produces a saturation profile that is 
equivalent to moderately severe obstructive sleep apnea in humans which is about 15 events per 
hour and an SpO2 = 75%.  
 
 
(0-30 seconds)                 
-N2 flushed into 
chamber until O2
concentration is 
10%.
(30-90 seconds)             
-O2 concentraion is 
maintained at 10%.
(90-120 seconds)            
-O2 flushed into 
chamber until 
concentration of 
20.9% O2 reached.
(120-300 seconds)        
-O2 concentration is 
maintained at 
20.9%.
IV. Cohorts 
i. CIH with 5TGM1, n=11  
ii. CIH with saline, n= 5 
iii. Normoxia with 5TGM1, n=8 
iv. Normoxia with saline, n=11 
v. Static hypoxia with 5TGM1, n=11 
vi. Static hypoxia with saline, n= 4  
vii. KaLwRij with 5TGM1, n=10 
viii. KalwRij with saline, n=5. 
 
V. Experimental Design 
 
 The mice were preconditioned for 7 days with either CIH, static hypoxia or normoxia in their 
environmental control chambers and were injected with 1x106 5TGM1 cells or saline 
intravenously through the tail on Day 7. The mice continued to experience their set condition 
until Day 28, when all mice were returned to normal housing. After returning the mice to their 
normal housing, they were monitored daily for disease symptoms such as paralysis form hips 
down, loss of weight and spinal deformities. The 5TGM1 cells were engineered to express green 
fluorescent protein in order to visualize the cells in sections of bone and spleen were used for 
imaging and flow cytometry.  
Flow Cytometry: One Femur and one Tibia as well as half of the spleen from the euthanized 
mouse were used for flow cytometry. The bone marrow was flushed with PBS using a needle 
and syringe from the femur and the tibia. The half spleen was minced between two cover slides. 
Cells from bone marrow and spleen in PBS were transferred to two 50ml conical centrifuge tube 
(one for each) passing through disposable 40µm cell strainer. The cell suspension was 
centrifuged (5000rpm, 5 min), re-suspended in 10ml of ACK lysing buffer (M.K Medical, 
Columbia, Maryland), centrifuged and then washed with PBS. Finally, Samples were run and 
analyzed using Becton Dickinson LSR II (BD Biosciences, San Jose, CA). 
Histology: The other femur and tibia were first decalcified by incubating it in EDTA for 2 
weeks. The bones as well as the other half of the spleen were fixed and embedded in paraffin.  
Sections were stained with hematoxylin and eosin (H&E). Olympus BX-61 light microscope was 
used to examine the slides and obtain images. 
3D X-ray: The tail and spine were imaged using a submicron 3D X-ray microscope; Zeiss 
Xradia 520 Versa. The samples were scanned at 70 kV/6 watts, a full 360º rotation over 1601 
projections, one second exposure time.  The projections were reconstruction into a single 3d 
image (CT) and reconstruction pixel size is 38 microns using ORS Visual software. Images were 
blindly reviewed by an independent radiologist. ImageJ software and BoneJ plugin19 was used to 
convert binary image into 3D mesh for quantification of bone lesions20 as well as to create the 
local thickness map and calculate trabecular bone thickness using 3D ROI manager. 
Cohorts placed in 
chambers Day 1 and 
remained so until Day 
28.
Day 7, cohorts were 
either injected with 
1x10^6 5TGM1 cells 
or saline. 
Day 28, cohorts 
returned to normal 
housing and monitored 
for disease: paralysis 
from hips down and 
loss of weight.
VI. Statistics  
Odds ratio was used for the statistical analysis of Experiment 1.  
 
Cohorts Odds Ratio          
(Confidence Interval) 
p-value 
Normoxia with 5TGM1 1.0  
Static Hypoxia with 5TGM1 5.7 (0.5-62.7) 0.117 
CIH with 5TGM1 17.5 (1.6-192.3) 0.005 
  
 
Experiment 2: Effect of CIH on 5TGM1 cells in Vitro 
I. Malignant Plasma Cell Line. 
 5TGM1 cells are murine myeloma cells that were derived from multiple myeloma in 
C57BL/KaLwRij mice. Multiple myeloma occurs spontaneously in aged C57BL/KaLwRij 
mice with no external stimulus such as CIH being required. The 5TGM1 cells used in our 
experiments were genetically engineered to express green fluorescent protein (GFP). The 
cells were cultured in RPMI 1640 medium (ATCC modification) (GIBCO, Grand Island, 
New York, USA) supplemented with 10% fetal bovine serum (HyClone Laboratories, Logan, 
Utah) and 1% penicillin-streptomycin solution (Mediatech, Manassas, Virginia) at 37ºC in 
5% CO2 atmosphere. 
II. Chronic Intermittent Hypoxia (CIH) Exposure 
 5TGM1 cells experienced CIH in a petri dish set inside of an environmental control chamber 
which was inside of an incubator set at normoxia with 5% CO2. The CIH protocol was as 
follows: 10 hours of CIH during the light cycle due to the fact mice sleep during the light 
cycle, beginning of each cycle nitrogen was flushed into the chamber until 10% oxygen was 
reached within 30 seconds, 10% oxygen was maintained inside of the chamber for an 
additional 60 seconds, lastly oxygen is flushed into the chamber until a concentration of 21% 
O2 is reached and this is maintained until the end of the 5 minute cycle. The CIH cycles are 
repeated for a duration of 10 hours or 120 cycles in total during the light cycle of the day. 
This CIH protocol produces a saturation profile that is equivalent to moderately severe 
obstructive sleep apnea in humans which is about 15 events per hour and an SpO2 = 75%. 
III. Experiment 2A: Determining Optimal Growth Concentration  
a. Conditions 
i. 5x106 per mL 
ii. 1x106 per mL 
iii. 5x105 per mL 
iv. 1x104 per mL 
b. Experimental Design 
5TGM1 plated on 
Day 1 at  5x106, 
1x106, 5x105, and 
1x104 cells per mL.
Concentrations 
measured daily 
until Day 4.
Concentration that 
showed the greatest 
proliferation Day 4 
was used for 
Experiment 2b. 
  An experiment was done to determine the concentration of 5TGM1 cells that showed the 
greatest proliferation in a 4 day period. The different concentrations that were tested were the 
following: 5x106, 1x106, 5x105, and 1x104 cells per mL. The cells were plated a 24 well plate 
with each concentration in a row of 6 wells. The concentrations were recorded daily in triplicate 
and the data was gathered using a hemocytometer. 
IV. Experiment 2B: Effect of CIH and Static Hypoxia in Vitro 
a. Conditions 
i. Normoxia (Static) 
ii. Chronic Intermittent Hypoxia  
iii. Static Hypoxia 
 
b. Experimental Design  
 
 Three groups of 5TGM1 cells were plated in separate gas permeable plates on Day 1. The plate 
that experienced normoxia was placed in an incubator while the two other groups were placed in 
environmental control chambers that experienced their assigned conditions. The concentrations 
of each group were recorded daily in triplicate using a hemocytometer.  
 
 
V. Statistics 
Area under the curve was used for statistical analysis for Experiment 2.  
 
Conditions Significant Adjusted p-value 
Normoxia vs. CIH Yes 0.0003 
Normoxia vs. Static Hypoxia Yes <0.0001 
 
 
 
 
 
 
 
5x105 5TGM1 cells 
plated in gas permeable 
wells Day 1.
Cells placed in 
chamber with either the 
CIH or static hypoxia. 
The third group was 
placed in normoxic 
conditions. 
Each group 
concentrations were 
counted daily in 
triplicate until Day 4. 
RESULTS 
Experiment 1: Engraftment and Progression of Multiple Myeloma Cells in Vivo with CIH 
or Static Hypoxia 
 The survival curve (Figure 1) shows the results of the different cohorts. None of the mice 
exposed to static hypoxia or CIH injected with saline died within the observation the observation 
period. One mouse exposed to normoxia and injected with saline died 45 days after injection, but 
did not appear to have suffered weight loss or paralysis that is consistent with the 5TGM1 model. 
The positive control, KalwRij mice injected with 5TGM1 cells (n=10), all developed paralysis 
and were euthanized. The C57BL/6 mice injected with 5TGM1 multiple myeloma cells (n=8) 
showed resistance to development of multiple myeloma, with only one mouse developing 
terminal paralysis. However, 67% of the CIH exposed C57BL/6 mice and 37% of static hypoxia 
exposed C57BL/6 mice developed terminal paralysis. CIH exposed mice had significantly worse 
chance of survival compared to normoxic controls with an odds ratio of (17.5, 95% CI 1.6-192.3, 
p=0.005). On the other hand, static hypoxia’s effect on the development of terminal paralysis 
was not statistically significant when compared to controls with an odds ratio of odds ratio (5.7, 
95% CI 0.5-62.7, p=0.117).  
 Our 5TGM1 cell line expresses green fluorescent protein (GFP+) which allowed detection and 
quantification of the myeloma cell burden in both the bone marrow and spleen of mice with 
terminal paralysis using flow cytometry analysis (Figure 3). Immunoglobulin levels and 
distribution of GFP+ 5TGM1 cells in bone marrow and spleen of CIH-exposed mice were one 
of the indicators of multiple myeloma engraftment. Increased monoclonal immunoglobulin is 
also a hallmark of MM. Serum was drawn from the paralyzed CIH exposed and KalwRij mice 
and tested for monoclonal immunoglobulin production which is shown in (Figure 3). Consistent 
with previous findings in the model, serum IgG2b was elevated in paralyzed KalwRij mice. The 
multiple myeloma specific monoclonal immunoglobulin G (IgG2b) level was elevated in 
paralyzed CIH mice which confirms the proliferation of malignant monoclonal plasma cells in 
the bone marrow. Interestingly, IgG2b level in the paralyzed CIH mice was significantly lower 
than its level in our positive control Kalwrij mice (median IgG2b level in paralyzed CIH = 4.7 
mg/ml vs 9.4 mg/ml in Kalwrij, p-value = 0.015). In the positive control, Kalwrij mice, GFP+ 
cells were highly abundant in the bone marrow and spleen. The cell content was about 50% 
GFP+ and the distribution between the two tissues was similar. Although the CIH exposed mice 
developed the same severity of paralysis, and appeared phenotypically like the Kalwrij mice, the 
tumor burden was significantly lower than in Kalwrij mice.  There was also a tendency for cells 
to engraft preferentially in the bone marrow which is evident by the more abundant GFP+ cells 
seen in the bone marrow compared to the spleen (Figure 3). The engraftment of GFP+ cells is six 
times higher in the bone marrow than the spleen of CIH-exposed mice.  
 Histopathology and 3D X-ray of bone in CIH exposed mice.  We used 3D X-ray to scan the 
lumbar and tail vertebral bones from the paralyzed mice of the CIH exposed cohort and 
normoxia control cohort. The images were then blindly reviewed by an independent investigator 
with radiology expertise. More lytic bone lesions were seen in the paralyzed CIH mice cohort 
compared to the normoxia control cohort (median number of lesions in paralyzed (CIH = 25 vs 9 
in normal controls, p-value = 0.015). A similar trend was seen regarding bone thickness as well 
(median bone thickness in paralyzed CIH = 175 µm vs 236 µm in normal controls, p-value = 
0.015). The bone marrow of mice in the normoxia control cohort and CIH cohort were made into 
slides that were stained with hematoxylin and eosin and then sent for histopathological 
examination, which showed sheets of monotonous malignant plasma cells with eccentric nuclei 
and dark chromatin infiltrating the bone marrow cavity to different degrees in Kalwrij mice 
versus paralyzed CIH-exposed mice. In the case of Kalwrij mice, the bone marrow cavity was 
completely obliterated with sheets of malignant cells, while in the paralyzed CIH-exposed mice 
areas of scattered patches of malignant plasma cells were found that ranged from 0% to 90% of 
the total area of the bone marrow sections (Figure 4).  
 
Experiment 2: Effect of CIH and Static Hypoxia on growth of 5TGM1 cells in culture 
 5TGM1 cells grown in 21% oxygen proliferated to double their original concentration over the 3 
day period (5x105 vs 11.6±1.1x105 cells/mL, p=0.002). There was no change in the concentration 
of cells grown in CIH with an oxygen nadir of 10% at Day 3, while cell concentration decreased 
in 10% and 1.5% static hypoxia and CIH with an oxygen nadir of 1.5% (0.5±0.4x105 cells/mL, 
p=0.006; 1.2±0.3x105 cells/mL, p=0.006; and 2.2±0.6x105 cells/mL, p=0.04, respectively) 
(Figure 5, Top). An evaluation of the area under the curve showed cell concentration for both 
CIH and both static hypoxia conditions were reduced compared to the normoxic control (Figure 
5, Bottom). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 Our study demonstrates that although CIH does not promote myeloma cell growth and 
proliferation in culture, in live animals CIH creates a hospitable environment permitting the 
engraftment and growth of malignant plasma cells in the bone marrow of otherwise myeloma 
resistant C57BL6 mice. 
 Clinical studies have shown an association between elevated body mass index (BMI) and risk of 
development of multiple myeloma. However, the underlying mechanism for this well 
documented link has not been fully understood. A study by Lwin et al. examined the effects of 
high fat diet on the development of MM in C57BL6 mice. Mice in their study were fed with high 
fat diet for 5 weeks and then injected with 5TGM1 MM cells. These mice only developed a 
MGUS-like condition as evidenced by elevated serum para-protein level which reverted to 
control levels on cessation of the high fat diet. Obstructive sleep apnea (OSA) is a condition that 
is closely associated with obesity. The risk factors for OSA are nearly identical to the risk factors 
for MM such as the eldery above 65 years old, men, and with high body mass index1, 12, 21. Given 
these similarities between both conditions, we set to study the effect of CIH which is a 
characteristic of obstructive sleep apnea on MM developement. The CIH protocol used in the 
experiments mimicked the hypoxia pattern seen in moderate OSA patients. When the MM 
resistant C57BL6 mice were exposed to CIH and then injected with 5TGM1 MM cells, these 
mice developed a phenotype of symptomatic MM like that observed in the Kalwrij mice. This 
phenotype is characterized by paralysis, bone lesions, decreased bone thickness, elevated 
monoclonal immunoglobulin IgG2b production and sheets of monotonous malignant plasma 
cells detected on the histological examination of H&E stained bone marrow slides and quantified 
using flow cytometry. Kalwrij is a mice strain that is susceptible to MM and that is why they 
served as the positive control and from which the 5TGM1 MM cells were originally derived6-8.   
 How might CIH change the bone marrow microenvironment to promote the engraftment of 
MM cells? In vitro CIH did not promote 5TGM1 cell proliferation; suggesting that the results we 
observed in experiment 1 were produced by CIH influencing the bone marrow microenvironment 
and/or altering the interaction of 5TGM1 cells with the host immune system. Tumor 
angiogenesis is hypothesized to be one of the mechanisms by which CIH promotes MM tumor 
development. A key transcriptional factor for several genes involved in angiogenesis in both 
normal physiological settings and in neoplastic settings22 is hypoxia-inducible factor (HIF). HIF 
upregulates the transcription of angiogenic growth factors like vascular endothelial growth factor 
(VEGF) leading to the proliferation, migration, assembly and lumen acquisition of endothelial 
cells and increased angiogenesis. Another mechanism that was hypothesized as a mechanism by 
which CIH promotes MM tumor development is that CIH alters the host immune response to 
cancer. It has been shown that intermittent hypoxia functionally changes tumor associated 
macrophages which in turn enhances tumor proliferation, migration, invasion, and extravasation 
properties23. CIH was, also, shown to act as a pro-inflammatory stimulus because it induces 
induces interleukin (IL)-6 expression which is a pro-inflammatory cytokine involved in T-cell 
proliferation, B-cell differentiation, and monocyte maturation24. A study by Dechow et al. shows 
IL-6’s involvement in the pathogenesis of MM. In the study IL-6/IL-6 receptor activation starts 
downstream signaling process that induce a disease strongly resembling human MM 25. While 
our study establishes the link between CIH exposure and development of MM, further studies are 
needed to fully investigate and understand the underlying mechanisms of the linkage. 
 Why do CIH-exposed mice experience enhanced bone damage despite a lower tumor burden? 
Quantification of both flow cytometry and ELISA monoclonal IgG2b showed that CIH exposed 
mice had significantly lower tumor burden compared to Kalwrij mice. However, the phenotype 
developed by both cohorts of mice strains were identical. This suggests that multiple myeloma 
cells in CIH exposed mice were more aggressive. Studies of solid tumors have shown that 
intermittent hypoxia increases the tumor’s aggressiveness, and metastatic properties13, 26. A 
possible explanation can be that CIH selects for the most aggressive, apoptosis-resistant 
population of tumor cells. Interestingly, we also observed that myeloma cells preferentially 
populated the bone marrow with minimal number of myeloma cells detected in the spleen in the 
CIH exposed mice cohort. In the Kalwrij mice cohort, the myeloma cells equally populated the 
spleen and the bone marrow. Myeloma cells specific engraftment in the bone marrow may be 
caused by a special interaction between bone marrow stromal cells treated with CIH and the 
myeloma cells. The importance of this study is significant because if sleep apnea does directly or 
indirectly promote engraftment of MM cells, then it may be prevented by being more cautious of 
sleep apnea symptoms and treating sleep apnea.  
Limitations: In our study, we established a link between CIH exposure and MM development, 
but we were not able to answer all the questions that arose about the underlying mechanisms. In 
the future studies, we are going to address the effects of CIH on angiogenesis in the bone marrow 
and its effect on the host immune system. 
 
 
Figures 
 
 
Figure 1: Kaplan Meier Survival Curve with Statistics. Top: Kaplan-Meier curve showing 
survival of all mice cohorts. Among the black6 mice, CIH exposed cohort with 5TGM1 injection 
experienced worst survival rate. Bottom: Odds ratio for developing paralysis as a result of 
myeloma is significantly higher in CIH exposed mice compared to controls under normal O2. 
 Figure 2: Experiment 1 Timeline. Timeline for experiment 1 included one week of 
preconditioning the mice with their assigned protocols (CIH, static hypoxia, normoxia). On day 
0, seven days since start of preconditioning, mice were injected with either 5TGM1 cells or PBS. 
The mice then continued their protocol in exposure chambers for 4 more weeks. On day 28, the 
mice were returned to normal housing where they were under daily observation for signs of 
paralysis. Paralyzed mice were euthanized, and tissues were collected for examination using flow 
cytometry, histology, and radiology. 
 
 
 Figure 3: Flow Cytometry. Right: Flow cytometry shows GFP+ 5TGM1 MM cells in the bone 
marrow (top) and spleen (below) of a paralyzed C57BL/6 mouse exposed to CIH. Left: Flow 
cytometry showing GFP+ 5TGM1 cells in the bone marrow (top) and spleen (below) of a 
paralyzed Kalwrij mouse. Bottom: Tumor cell burden was higher in the bone marrow and spleen 
of Kalwrij mice compared to paralyzed CIH exposed mice. The myeloma cells in bone marrow 
to spleen ratio showed equal distribution in Kalwrij mice, but in CIH exposed C57BL/6 mice it 
was seen that tumor engraftment favored the bone marrow.  
** P-value <0.001 
 
 Figure 4: Bone Damage on Micro-CT. A: 3D bone surface mesh image used for bone lesions 
counting (left), and bone thickness heat map image (right) of the tail and spine of a control 
mouse B: 3D mesh (left), and bone thickness heat map images (right) of the tail and spine of a 
CIH exposed mouse C: Bone thickness comparison showing decreased bone thickness in the 
CIH exposed cohort p=0.004 D: CIH exposed cohort had higher number of bone lesions 
compared to control p=0.047 E: hematoxylin & eosin stained slide of the bone marrow of a CIH 
exposed mouse showing malignant plasma cells infiltrating the bone cavity F: hematoxylin & 
eosin stained slide showing normal bone marrow of a control mouse. 
0 1 2 3
0 .0
2 .5
5 .0
7 .5
1 0 .0
1 2 .5
1 5 .0
T im e  (d a y s )
C
e
ll
 C
o
n
c
e
n
tr
a
ti
o
n
 (
x
1
0
5
)
N o rm o x ia  (2 1 %  O 2 )
C IH  (N a d ir ,  1 0 %  O 2 )
H y p o x ia  (1 0 %  O 2 )
C IH  (N a d ir ,  1 .5 %  O 2 )
H y p o x ia  (1 .5 %  O 2 )
N o rm o x ia
(2 1 % )
C IH
(1 0 % )
C IH
(1 .5 % )
H y p o x ia
(1 0 % )
H y p o x ia
(1 .5 % )
0
1 0
2 0
3 0
4 0
A
r
e
a
 U
n
d
e
r
 t
h
e
 C
u
r
v
e
* * *
* * *
* * *
* *
 
Figure 5: Cell Growth. Above: Changes in 5TGM1 cell concentration over the time of 3 days 
while exposed to different O2 conditions was significantly different. Normoxia is the normal 
oxygen condition at 20.9%; cells double within 72-hours. CIH (10%) is chronic intermittent 
hypoxia fluctuating between 20.9% and 10% O2 concentration, CIH (1.5%) is chronic 
intermittent hypoxia fluctuating between 20.9% and 1.5% O2 concentration, static hypoxia is 
exposed to 10%O2: the three groups showed lower cell growth compared to control. Below: area 
under the curve showing cells exposed CIH (10%), CIH (1.5%), and static hypoxia had less 
growth compared to normoxia. 
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